Worcestershire Acute Hospitals NHS Trust is an NHS trust which runs three hospitals in Worcestershire, England: The Alexandra Hospital, Redditch, Kidderminster Hospital and Treatment Centre in Kidderminster, Evesham hospital Burlingham ward in Evesham and the Worcestershire Royal Hospital in Worcester.

During the past decade, Worcestershire Royal Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Worcestershire Royal Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "Medical Research Council" with 3 trials sponsored, "University of Leeds" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Cancer Research Campaign Clinical Trials Centre" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Worcestershire Royal Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Worcestershire Royal Hospital" are "Breast Cancer" (9 trials), "Colorectal Cancer" (5 trials), "Multiple Myeloma" (3 trials), "Lung Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Worcestershire Royal Hospital" in a lesser frequency.

Most popular intervention types in "Worcestershire Royal Hospital" are "Drug" (28 trials), "Procedure" (12 trials), "Radiation" (8 trials), "Biological" (7 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (5 trials), "adjuvant therapy" (4 trials), "radiation therapy" (4 trials), "cetuximab" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Worcestershire Royal Hospital" are 34 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Worcestershire Royal Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Worcestershire Royal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Worcestershire Royal Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".